BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
July 27, 2022 at 11:55 am EDT
Share
BioForce Nanosciences Holdings, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 0.115784 million compared to USD 0.122315 million a year ago.
For the six months, net loss was USD 0.248192 million compared to USD 0.267394 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
BioForce Nanosciences Holdings, Inc. is a provider of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The Company markets its products through social media and telemarketing. The Company seeks to expand its BioForce Eclipse nutritional powder for use into households throughout the United States. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, focuses to be the channels for the Companyâs Eclipse product lines. The Company private labels the powder through a manufacturer located in Virginia. The Company caters to the needs of customers with a focus on the elderly and athletes across numerous sports, ages, and economic backgrounds. The Company also focuses on offering its products for direct sales on its Website at www.bioforceeclipse.com. The Companyâs wholly owned subsidiary is Element Global, Inc.
BIOFORCE NANOSCIENCES HOLDINGS, INC. 
